| Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection DS Khoury, D Cromer, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... Nature medicine 27 (7), 1205-1211, 2021 | 3683 | 2021 |
| Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... The Lancet Microbe 3 (1), e52-e61, 2022 | 523 | 2022 |
| Analysis of the Phthiocerol Dimycocerosate Locus ofMycobacterium tuberculosis: Evidence that this lipid is involved in the cell wall permeability barrier LR Camacho, P Constant, C Raynaud, MA Lanéelle, JA Triccas, ... Journal of Biological Chemistry 276 (23), 19845-19854, 2001 | 450 | 2001 |
| Cutaneous immunosurveillance by self-renewing dermal γδ T cells N Sumaria, B Roediger, LG Ng, J Qin, R Pinto, LL Cavanagh, ... The Journal of experimental medicine 208 (3), 505, 2011 | 309 | 2011 |
| Migratory dermal dendritic cells act as rapid sensors of protozoan parasites LG Ng, A Hsu, MA Mandell, B Roediger, C Hoeller, P Mrass, ... PLoS pathogens 4 (11), e1000222, 2008 | 286 | 2008 |
| Animal and translational models of SARS-CoV-2 infection and COVID-19 MD Johansen, A Irving, X Montagutelli, MD Tate, I Rudloff, MF Nold, ... Mucosal immunology 13 (6), 877-891, 2020 | 194 | 2020 |
| An inducible expression system permitting the efficient purification of a recombinant antigen from Mycobacterium smegmatis JA Triccas, T Parish, WJ Britton, B Gicquel FEMS microbiology letters 167 (2), 151-156, 1998 | 171 | 1998 |
| Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis PW Roche, N Winter, JA Triccas, CG Feng, WJ Britton Clinical & Experimental Immunology 103 (2), 226-232, 1996 | 124 | 1996 |
| Leads for antitubercular compounds from kinase inhibitor library screens S Magnet, RC Hartkoorn, R Székely, J Pató, JA Triccas, P Schneider, ... Tuberculosis 90 (6), 354-360, 2010 | 122 | 2010 |
| Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? SJ Kent, DS Khoury, A Reynaldi, JA Juno, AK Wheatley, E Stadler, ... Nature Reviews Immunology 22 (6), 387-397, 2022 | 114 | 2022 |
| New tuberculosis drug leads from naturally occurring compounds D Quan, G Nagalingam, R Payne, JA Triccas International Journal of Infectious Diseases 56, 212-220, 2017 | 113 | 2017 |
| BCG vaccination against tuberculosis: past disappointments and future hopes PW Roche, JA Triccas, N Winter Trends in microbiology 3 (10), 397-401, 1995 | 113 | 1995 |
| Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity Y Luo, H Yamada, X Chen, AA Ryan, DP Evanoff, JA Triccas, ... Clinical & Experimental Immunology 137 (1), 24-34, 2004 | 110 | 2004 |
| The Mycobacterium tuberculosis cysD and cysNC genes form a stress-induced operon that encodes a tri-functional sulfate-activating complex R Pinto, QX Tang, WJ Britton, TS Leyh, JA Triccas Microbiology 150 (6), 1681-1686, 2004 | 103 | 2004 |
| Plasmid Interleukin-23 (IL-23), but Not Plasmid IL-27, Enhances the Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection TM Wozniak, AA Ryan, JA Triccas, WJ Britton Infection and immunity 74 (1), 557-565, 2006 | 99 | 2006 |
| A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae JA Triccas, PW Roche, N Winter, CG Feng, CR Butlin, WJ Britton Infection and immunity 64 (12), 5171-5177, 1996 | 98 | 1996 |
| Use of fluorescence induction and sucrose counterselection to identify Mycobacterium tuberculosis genes expressed within host cells JA Triccas, FX Berthet, V Pelicic, B Gicquel Microbiology 145 (10), 2923-2930, 1999 | 87 | 1999 |
| Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guerin from infection with Mycobacterium tuberculosis PW Roche, JA Triccas, DT Avery, T Fifis, H Billman-Jacobe, WJ Britton Journal of Infectious Diseases 170 (5), 1326-1330, 1994 | 86 | 1994 |
| Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection DS Khoury, TE Schlub, D Cromer, M Steain, Y Fong, PB Gilbert, ... Emerging Infectious Diseases 29 (2), 381, 2023 | 82 | 2023 |
| Coexpression of Interleukin-12 Chains by a Self-Splicing Vector Increases the Protective Cellular Immune Response of DNA and Mycobacterium bovis BCG Vaccines against … U Palendira, AT Kamath, CG Feng, E Martin, PJ Chaplin, JA Triccas, ... Infection and immunity 70 (4), 1949-1956, 2002 | 82 | 2002 |
